Dr. Ronald Schwarz, MD

NPI: 1508905043
Total Payments
$11,337
2024 Payments
$1,801
Companies
44
Transactions
551
Medicare Patients
1,927
Medicare Billing
$257,361

Payment Breakdown by Category

Food & Beverage$10,534 (92.9%)
Consulting$450.00 (4.0%)
Travel$234.40 (2.1%)
Education$117.93 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,534 545 92.9%
Consulting Fee $450.00 3 4.0%
Travel and Lodging $234.40 1 2.1%
Education $117.93 2 1.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $2,594 145 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,185 63 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $995.66 56 $0 (2024)
PFIZER INC. $741.72 36 $0 (2024)
Boston Scientific Corporation $511.20 7 $0 (2023)
Biogen, Inc. $450.00 3 $0 (2023)
Allergan Inc. $443.74 45 $0 (2018)
Gilead Sciences, Inc. $403.41 24 $0 (2024)
Janssen Biotech, Inc. $382.68 11 $0 (2024)
E.R. Squibb & Sons, L.L.C. $336.08 3 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,801 69 Janssen Biotech, Inc. ($310.96)
2023 $1,543 68 AbbVie Inc. ($289.91)
2022 $1,699 73 ABBVIE INC. ($391.71)
2021 $755.01 30 AbbVie Inc. ($211.59)
2020 $215.27 13 AbbVie Inc. ($57.99)
2019 $2,235 96 AbbVie, Inc. ($567.92)
2018 $2,056 115 AbbVie, Inc. ($598.15)
2017 $1,034 87 AbbVie, Inc. ($202.94)

All Payment Transactions

551 individual payment records from CMS Open Payments — Page 3 of 23

Date Company Product Nature Form Amount Type
04/09/2024 PFIZER INC. VELSIPITY (Drug) Food and Beverage In-kind items and services $82.02 General
Category: INFLAMMATION;PAIN
04/01/2024 ABBVIE INC. CREON (Drug), VIBERZI, LINZESS Food and Beverage In-kind items and services $8.19 General
Category: ENDOCRINOLOGY
03/28/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $13.17 General
Category: INTERNAL MEDICINE
03/25/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $28.90 General
Category: Immunology
03/13/2024 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $18.81 General
Category: GASTROENTEROLOGY
03/11/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $16.88 General
Category: IMMUNOLOGY
03/06/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $19.45 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
03/06/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.79 General
Category: Gastroenterology
02/28/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $16.12 General
Category: GASTROENTEROLOGY
02/27/2024 Merck Sharp & Dohme LLC DIFICID (Drug) Food and Beverage In-kind items and services $17.50 General
Category: INFECTIOUS DISEASE
02/26/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $19.81 General
Category: Immunology
02/07/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $21.59 General
Category: GASTROENTEROLOGY
02/06/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $17.24 General
Category: Neuroscience
01/31/2024 PFIZER INC. VELSIPITY (Drug) Food and Beverage In-kind items and services $48.71 General
Category: INFLAMMATION;PAIN
01/23/2024 Takeda Pharmaceuticals U.S.A., Inc. GATTEX (Drug) Food and Beverage In-kind items and services $15.66 General
Category: INTERNAL MEDICINE
01/23/2024 ABBVIE INC. HUMIRA (Biological), RINVOQ Food and Beverage In-kind items and services $14.70 General
Category: IMMUNOLOGY
01/18/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $16.05 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
01/08/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $20.67 General
Category: INTERNAL MEDICINE
01/03/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.40 General
Category: Gastroenterology
12/18/2023 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $15.97 General
Category: GASTROENTEROLOGY
12/15/2023 Fresenius Kabi USA, LLC IDACIO (Biological) Food and Beverage In-kind items and services $17.70 General
Category: Biosimilars
12/13/2023 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $19.73 General
Category: Immunology
12/12/2023 Boston Scientific Corporation Food and Beverage In-kind items and services $45.67 General
Category: General - EndoChoice_ENDO
12/05/2023 Merck Sharp & Dohme LLC DIFICID (Drug) Food and Beverage In-kind items and services $19.86 General
Category: INFECTIOUS DISEASE
12/04/2023 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $15.25 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 317 317 $408,396 $43,716
2022 9 448 450 $565,369 $57,997
2021 12 478 478 $588,252 $67,125
2020 17 684 687 $833,944 $88,523
Total Patients
1,927
Total Services
1,932
Medicare Billing
$257,361
Procedure Codes
47

All Medicare Procedures & Services

47 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 85 85 $140,250 $16,262 11.6%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 44 44 $53,900 $7,586 14.1%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 32 32 $38,208 $5,493 14.4%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 30 30 $39,450 $4,210 10.7%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 35 35 $49,455 $3,795 7.7%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2023 20 20 $23,736 $2,087 8.8%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 29 29 $27,988 $1,796 6.4%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 27 27 $30,564 $1,756 5.7%
91010 Study of esophagus to assess movement Facility 2023 15 15 $4,845 $731.10 15.1%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 103 103 $169,950 $18,502 10.9%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 55 55 $65,670 $9,596 14.6%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 64 64 $84,160 $8,954 10.6%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 35 35 $42,875 $6,049 14.1%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 45 45 $63,585 $4,667 7.3%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 46 46 $43,838 $3,400 7.8%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 51 51 $57,732 $3,361 5.8%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2022 24 26 $29,484 $2,195 7.4%
91010 Study of esophagus to assess movement Facility 2022 25 25 $8,075 $1,273 15.8%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 110 110 $181,500 $21,745 12.0%
45378 Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk Facility 2021 67 67 $87,073 $9,551 11.0%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2021 39 39 $46,566 $7,201 15.5%
91110 Imaging of digestive tract done from the inside of the digestive tract Office 2021 11 11 $29,348 $6,791 23.1%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 54 54 $76,302 $5,135 6.7%
43235 Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 53 53 $49,736 $4,072 8.2%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2021 21 21 $25,725 $3,883 15.1%

About Dr. Ronald Schwarz, MD

Dr. Ronald Schwarz, MD is a Gastroenterology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508905043.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Schwarz, MD has received a total of $11,337 in payments from pharmaceutical and medical device companies, with $1,801 received in 2024. These payments were reported across 551 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($10,534).

As a Medicare-enrolled provider, Schwarz has provided services to 1,927 Medicare beneficiaries, totaling 1,932 services with total Medicare billing of $257,361. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Raleigh, NC
  • Active Since 02/05/2007
  • Last Updated 01/29/2009
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1508905043

Products in Payments

  • XIFAXAN (Drug) $823.62
  • ENTYVIO (Biological) $635.27
  • ZEPOSIA (Drug) $525.29
  • STELARA (Biological) $523.86
  • TYSABRI (Biological) $450.00
  • SKYRIZI (Biological) $441.08
  • DUPIXENT (Biological) $397.19
  • XELJANZ (Drug) $373.65
  • LINZESS (Drug) $372.43
  • Cimzia (Drug) $310.14
  • Humira (Biological) $295.19
  • Entyvio (Biological) $261.29
  • GENERAL THERAPIES (Device) $234.40
  • INFLECTRA (Biological) $220.14
  • Creon (Drug) $218.50
  • XIFAXANIBSD (Drug) $211.44
  • HUMIRA (Biological) $199.81
  • TRULANCE (Drug) $198.02
  • ZENPEP (Drug) $197.45
  • RINVOQ (Biological) $176.12

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Raleigh